Donepezil vs Rituximab

## Donepezil vs Rituximab: Overview

This comparison examines the pharmacological differences between **Donepezil** and **Rituximab**.

## Mechanism of Action

**Donepezil**: Reversible acetylcholinesterase inhibitor.

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Donepezil — 70 hours; Rituximab — 22 days.

## Chemical Properties

**Molecular Formula**: Donepezil — C24H29NO3; Rituximab — N/A.

**Molecular Weight**: Donepezil — 379.4920 g/mol; Rituximab — N/A.

**Type**: Donepezil — Small molecule; Rituximab — Antibody.